Announced Thu, 8 Oct, 2026 · 18:47 IST

Routine compliance certificate for Q2 FY26 (Reg 74(5))

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.8%Reaction day

₹68.11

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+2.5% vs market

Medical Equipment & Supplies peers, median of 13sector-0.3%+3.1% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 3.1 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.8+0.3+2.5-0.3+3.1

Next day

-1.2+1.1-2.4-0.7-0.6

-0.9+1.3-2.2-2.5+1.6

—+2.0—-2.6—

-19.1+0.3-19.4-2.8-16.3

-9.1+1.1-10.2-2.1-7.0

-18.5-3.2-15.3-5.3-13.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Registrar Bigshare Services has confirmed that all shares of Amkay Products are held in demat form and no dematerialization requests were received during the quarter ended 30 September 2026. The regulation is therefore not applicable to the company. Signed by Managing Director Kashyap Pravin Mody.

Likely market impact

No impact on shareholders — this is a routine compliance filing confirming no share movement requests during the quarter.